Can isatuximab (Isatuximab-irfc) be used long-term?

Isatuximab (Isatuximab-irfc) may be considered as part of long-term treatment in some circumstances, particularly in patients with multiple myeloma (Multiple Myeloma, MM) as part of maintenance therapy. However, whether to use isatuximab long-term and the duration of the treatment plan will vary based on the patient's condition, response to treatment, and physician recommendations.

The following are some general facts about the long-term use of isatuximab:

1.Maintenance treatment: In some patients with multiple myeloma, once remission is achieved with initial treatment (including chemotherapy, stem cell transplantation, etc.), doctors may consider isatuximab as part of maintenance treatment to extend the remission period and reduce the risk of disease recurrence. This maintenance treatment is usually long-term and may take months or even years.

2.Treatment response: The decision whether to continue isatuximab usually depends on the patient's treatment response. If a patient responds well to isatuximab and other treatments and does not have serious side effects, the doctor may recommend continuing to use it to keep the disease under control.

3.Disease Progression: If a patient's multiple myeloma progresses, their treatment plan may need to be re-evaluated, including whether to continue isatuximab. In some cases, your doctor may consider changing or adjusting your treatment plan.

4.Side effects and drug resistance: Long-term use of any drug may cause side effects or cause patients to develop drug resistance. Therefore, doctors regularly monitor patients' condition and drug tolerance and make adjustments as needed.

It needs to be emphasized that the development of a treatment plan should be individualized and based on the patient's specific situation and the doctor's recommendations. Patients should communicate regularly with medical professionals and participate in decisions about treatment plans. In addition, patients should receive regular check-ups as directed by their doctor to ensure that the condition is effectively controlled and any side effects or disease progression are dealt with in a timely manner.